Breaking News

BrainStorm, PharmaNet in ALS Pact

PharmaNet to assist with IND protocol

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BrainStorm Cell Therapeutics has signed an agreement with PharmaNet LLC, a unit of inVentiv Health Co., to assist in the IND protocol development for the submission of BrainStorm’s NurOwn clinical trials in ALS patients. The drug was granted Orphan Drug Designation by the FDA as treatment for ALS. Dr. Joyce L. Frey-Vasconcells will be leading the efforts on behalf of PharmaNet. She currently serves as executive director of PharmaNet Consulting. “The agreement with PharmaNet brings us one step ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters